A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in health workers and others closely exposed to ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A surprising new study found the ...
Hydroxychloroquine did not slow progression from incomplete to full-blown systemic lupus erythematosus (SLE) in patients who had antinuclear antibody (ANA) positivity and met one or two SLE ...
The treatment of lupus is particularly complex for young patients who must commit to lifelong Hydroxychloroquine therapy, which carries a chance, although low, of eye toxicity. Patients often face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results